Forecast: Stomach Malignant Neoplasms Mortality in Canada

The mortality rate for stomach malignant neoplasms among men in Canada is forecasted to decrease from 5.9 per 100,000 in 2024 to 5.1 per 100,000 by 2028. This decline represents an average annual decrease (CAGR) of approximately 3.6%. The year-on-year reduction in mortality is consistent and indicates a positive trend in combatting this disease.

Future trends to watch for include advancements in early detection and treatment methods, as well as healthcare policies that could further lower the mortality rate. Monitoring shifts in demographics and healthcare accessibility may also provide insights into future changes in these statistics.